Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Jun 24, 2021
PPTA Responds to ProPublica Article
An article published by ProPublica on June 24 (“The U.S. Is Closing a Loophole That Lured Mexicans Over the Border to Donate Blood Plasma for Cash”) is the latest sensationalized reporting from ProPublica and ARD German TV reporters who continue to misrepresent and malign U.S. policies regarding plasma donation as well as the scores of committed individuals who cross the U.S.-Mexico border to donate their plasma.
All
PPTA statements
Jun 24, 2021
PPTA Responds to ProPublica Article
An article published by ProPublica on June 24 (“The U.S. Is Closing a Loophole That Lured Mexicans Over the Border to Donate Blood Plasma for Cash”) is the latest sensationalized reporting from ProPublica and ARD German TV reporters who continue to misrepresent and malign U.S. policies regarding plasma donation as well as the scores of committed individuals who cross the U.S.-Mexico border to donate their plasma.
All
PPTA statements
Jun 14, 2021
EU Health Commissioner says plasma donation plays a vital role
June 14, 2021 (Brussels, Belgium) – The Plasma Protein Therapeutics Association (PPTA) is proud to mark World Blood Donor Day.
All
Press releases
Jun 14, 2021
EU Health Commissioner says plasma donation plays a vital role
June 14, 2021 (Brussels, Belgium) – The Plasma Protein Therapeutics Association (PPTA) is proud to mark World Blood Donor Day.
All
Press releases
Jun 1, 2021
The Impact of Plasma-Derived Therapies in Europe: The Health and Economic Case for Ensuring Sustainable Supply
Plasma-derived therapies are therapies derived from human plasma. They are manufactured using a fractionation process where the relevant proteins in plasma are separated out.
All
Publication
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6452a91ce4031b0eac4db789_copenhagen-economics_the-impact-of-plasma-derived-therapies-in-europe_june-2021.pdf
Jun 1, 2021
The Impact of Plasma-Derived Therapies in Europe: The Health and Economic Case for Ensuring Sustainable Supply
Plasma-derived therapies are therapies derived from human plasma. They are manufactured using a fractionation process where the relevant proteins in plasma are separated out.
All
Publication
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6452a91ce4031b0eac4db789_copenhagen-economics_the-impact-of-plasma-derived-therapies-in-europe_june-2021.pdf
Apr 21, 2021
The revision of the EU Blood Directive: How to enhance plasma collection by getting more donors via increased regulatory efficiency?
The online event entitled “The revision of the EU Blood Directive: How to enhance plasma collection by getting more donors via increased regulatory efficiency?”, organized and hosted by Member of the European Parliament (MEP) Sirpa Pietikäinen took place on April 21, 2021.
All
Presentation
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6452a9246257dcb88916f0a7_Report_How_to_enhance_plasma_collection_April_2021.pdf
Apr 21, 2021
The revision of the EU Blood Directive: How to enhance plasma collection by getting more donors via increased regulatory efficiency?
The online event entitled “The revision of the EU Blood Directive: How to enhance plasma collection by getting more donors via increased regulatory efficiency?”, organized and hosted by Member of the European Parliament (MEP) Sirpa Pietikäinen took place on April 21, 2021.
All
Presentation
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6452a9246257dcb88916f0a7_Report_How_to_enhance_plasma_collection_April_2021.pdf
No results found